GPC1 and pancreatic neoplasm: GPC1 was recently identified as elevated in exosomes prepared from the serum of patients with pancreatic cancer [15] and may be involved in disease progression as a mediator of angiogenesis [16], although interestingly, a reduction of GPC1 was found to be predictive of disease in this case.